To hear about similar clinical trials, please enter your email below
Trial Title:
Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma
NCT ID:
NCT05694845
Condition:
Cholangiocarcinoma
Conditions: Official terms:
Cholangiocarcinoma
Conditions: Keywords:
Cholangiocarcinoma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
The main reason for conducting this research is to gain a better understanding of why
some people with cholangiocarcinoma are not able to participate in or complete clinical
trials. Historically, certain groups of people have been more likely to participate in
clinical trials, but there hasn't been much research to understand why this is the case.
The goal is to find out which aspects of a clinical trial may make it more difficult for
patients to take part or see it through. The data will be evaluated through different
demographic lenses and identify trends that could help improve the experience of future
cholangiocarcinoma patients during clinical trials.
Criteria for eligibility:
Study pop:
Cholangiocarcinoma patients who are actively considering involvement in an observational
clinical trial, but have not yet completed enrollment and registration.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient is at least 18 years of age
- Participant has a diagnosis of Cholangiocarcinoma
- Patient has self-identified as planning to enroll in an interventional
Cholangiocarcinoma clinical trial
- Patient must provide written informed consent
Exclusion Criteria:
- No diagnosis of Cholangiocarcinoma confirmed
- Inability to perform regular electronic reporting
- Women who are pregnant, intend to become pregnant, or are lactating
- Patient does not understand, sign, and return consent form
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
February 2024
Completion date:
February 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05694845
